BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17032889)

  • 21. Predictors of competing mortality in early breast cancer.
    Mell LK; Jeong JH; Nichols MA; Polite BN; Weichselbaum RR; Chmura SJ
    Cancer; 2010 Dec; 116(23):5365-73. PubMed ID: 20737562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of mammography on U.S. breast cancer mortality, 1975-2000: are intermediate outcome measures informative?
    Habbema JD; Tan SY; Cronin KA
    J Natl Cancer Inst Monogr; 2006; (36):105-11. PubMed ID: 17032900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years].
    Wang QJ; Zhu WX; Xing XM
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):208-10. PubMed ID: 16875607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The University of Rochester model of breast cancer detection and survival.
    Hanin LG; Miller A; Zorin AV; Yakovlev AY
    J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivot tables for mortality analysis, or who needs life tables anyway?
    Wesley D; Cox HF
    J Insur Med; 2007; 39(3):167-73. PubMed ID: 18251375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer mortality in Russia and Ukraine 1963-2002: an age-period-cohort analysis.
    Hirte L; Nolte E; Bain C; McKee M
    Int J Epidemiol; 2007 Aug; 36(4):900-6. PubMed ID: 17510071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent and distribution of inequalities in childhood mortality by cause of death according to parental socioeconomic positions: a birth cohort study in South Korea.
    Kim J; Son M; Kawachi I; Oh J
    Soc Sci Med; 2009 Oct; 69(7):1116-26. PubMed ID: 19695755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis using life tables of the major causes of death and the differences between country of birth groups in New South Wales, Australia.
    Weerasinghe DP; Parr NJ; Yusuf F
    Public Health; 2009 May; 123(5):351-7. PubMed ID: 19443003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MISCAN-Fadia continuous tumor growth model for breast cancer.
    Tan SY; van Oortmarssen GJ; de Koning HJ; Boer R; Habbema JD
    J Natl Cancer Inst Monogr; 2006; (36):56-65. PubMed ID: 17032895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Bayesian approach to competing risks analysis with masked cause of death.
    Sen A; Banerjee M; Li Y; Noone AM
    Stat Med; 2010 Jul; 29(16):1681-95. PubMed ID: 20575048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary flavonoid intake and breast cancer survival among women on Long Island.
    Fink BN; Steck SE; Wolff MS; Britton JA; Kabat GC; Gaudet MM; Abrahamson PE; Bell P; Schroeder JC; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2285-92. PubMed ID: 18006917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary cancer rates following breast cancer diagnosis.
    Wesley D
    J Insur Med; 2007; 39(2):98-106. PubMed ID: 17941334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Wisconsin Breast Cancer Epidemiology Simulation Model.
    Fryback DG; Stout NK; Rosenberg MA; Trentham-Dietz A; Kuruchittham V; Remington PL
    J Natl Cancer Inst Monogr; 2006; (36):37-47. PubMed ID: 17032893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of breast cancer mortality rates with those of ovarian and colorectal carcinoma.
    Stearns AT; Hole D; George WD; Kingsmore DB
    Br J Surg; 2007 Aug; 94(8):957-65. PubMed ID: 17377931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of poorer survival in pregnancy-associated breast cancer.
    Rodriguez AO; Chew H; Cress R; Xing G; McElvy S; Danielsen B; Smith L
    Obstet Gynecol; 2008 Jul; 112(1):71-8. PubMed ID: 18591310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.